Rays expect to be without Kyle Farnsworth for 4-6 weeks

Leave a comment

So much for Kyle Farnsworth’s elbow injury being a minor one.

Yesterday the Rays placed Farnsworth on the disabled list and today manager Joe Maddon told Marc Topkin of the Tampa Bay Times that he expects to be without the closer for 4-6 weeks.

No word yet on the fill-in closer, but most of the Rays’ beat writers expect Maddon to use a closer-by-committee approach initially, which means Joel Peralta is seemingly the favorite for saves and Fernando Rodney, J.P. Howell, and perhaps even Wade Davis could get into the ninth-inning mix.

Farnsworth saved 25 games with a 2.18 ERA and 51/12 K/BB ratio in 58 innings last season, but has been dealing with elbow problems since September.

Clayton Kershaw completes spring training with a 0.00 ERA

Getty Images

Clayton Kershaw had nothing left to prove when he exited the mound during his last Cactus League start on Friday. He finished camp with a 0.00 ERA, made all the more impressive after he extended his scoreless streak to 21 1/3 innings following 6 2/3 frames of one-hit ball against the Royals.

In six spring training starts this year, the Dodgers southpaw racked up 12 hits, four walks and 23 strikeouts. His velocity appeared to fluctuate between the high-80s and low-90s from start to start, but manager Dave Roberts told reporters that he expects Kershaw to get back up to the 93 m.p.h. range next week. Kershaw is tabbed for his eighth consecutive Opening Day start on Thursday.

The 30-year-old lefty is poised to enter his 11th season with the club in 2018. He went 18-4 in 27 starts last year and turned in a 2.31 ERA, 1.5 BB/9 and 10.4 SO/9 over 175 innings. He suffered his fair share of bumps and bruises along the way, including a lower back strain that required a five-week stay on the disabled list.

The Dodgers will open their season against the Giants on Thursday, March 29 at 7:08 PM ET. Given the sudden rash of injuries that hit the Giants’ rotation earlier today, Kershaw’s Opening Day opponent has not yet been announced.